Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Ionis Pharmaceutical (IONS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,466,188
  • Shares Outstanding, K 140,323
  • Annual Sales, $ 599,670 K
  • Annual Income, $ 273,740 K
  • 60-Month Beta 2.31
  • Price/Sales 15.77
  • Price/Cash Flow 21.06
  • Price/Book 6.82

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.26
  • Number of Estimates 8
  • High Estimate -0.05
  • Low Estimate -0.50
  • Prior Year -0.05
  • Growth Rate Est. (year over year) -420.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
63.19 +9.57%
on 05/08/19
75.63 -8.45%
on 04/22/19
-3.75 (-5.14%)
since 04/18/19
3-Month
57.25 +20.94%
on 02/22/19
86.58 -20.03%
on 04/08/19
+11.83 (+20.61%)
since 02/21/19
52-Week
40.91 +69.25%
on 06/28/18
86.58 -20.03%
on 04/08/19
+26.01 (+60.17%)
since 05/21/18

Most Recent Stories

More News
Biogen's SPINRAZA(R) (nusinersen) Receives Positive Recommendation from NICE for Funding in the United Kingdom for the Treatment of Infants, Children and Adults with Spinal Muscular Atrophy

Biogen Inc. (Nasdaq: BIIB) today announced that The National Institute for Health and Care Excellence (NICE) in the United Kingdom has recommended funding for SPINRAZA (nusinersen) on the National Health...

IONS : 69.24 (+2.64%)
BIIB : 232.92 (+0.94%)
Interesting IONS Put And Call Options For June 28th

Investors in Ionis Pharmaceuticals Inc saw new options become available today, for the June 28th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the IONS options...

IONS : 69.24 (+2.64%)
Ionis Pharmaceuticals (IONS) Beats Q1 Earnings and Revenue Estimates

Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of 113.95% and 3.27%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

IONS : 69.24 (+2.64%)
Ionis Pharmaceuticals: 1Q Earnings Snapshot

CARLSBAD, Calif. (AP) _ Ionis Pharmaceuticals Inc. (IONS) on Thursday reported first-quarter net income of $84 million, after reporting a loss in the same period a year earlier.

IONS : 69.24 (+2.64%)
Ionis reports first quarter 2019 financial results

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today reported its financial results for the first quarter of 2019 and recent business highlights.

IONS : 69.24 (+2.64%)
NVS : 82.39 (+0.46%)
Akcea Reports Financial Results and Highlights for First Quarter 2019

Achieved First Quarter 2019 TEGSEDI (inotersen) Global Net Product Revenues of $7 Million

AKCA : 22.17 (+11.30%)
IONS : 69.24 (+2.64%)
NVS : 82.39 (+0.46%)
Drug/Biotech Stock Q1 Earnings on May 9: IONS, XLRN & More

Five drug/biotech stocks are scheduled to release their first-quarter results on May 9. Let's take a look at how these companies are poised ahead of their earnings release.

GH : 76.38 (-2.41%)
PDLI : 3.04 (+2.01%)
MRK : 79.50 (+0.79%)
XLRN : 42.90 (+4.61%)
IONS : 69.24 (+2.64%)
BPMC : 78.97 (+4.07%)
PFE : 41.67 (+0.19%)
New Long-Term TEGSEDI Safety and Efficacy Data Featured as an Oral Presentation at 2019 American Academy of Neurology Annual Meeting (AAN)

NEURO-TTR phase 3 open-label extension study showed TEGSEDI(R) (inotersen) treatment continued to slow progression over two-year period in patients with Hereditary ATTR amyloidosis with polyneuropathy

AKCA : 22.17 (+11.30%)
IONS : 69.24 (+2.64%)
After Yesterday's Decline of 4.95%, Ionis Pharmaceut Offers Investors Better Value

Ionis Pharmaceut (NASDAQ:IONS) traded in a range yesterday that spanned from a low of $67.13 to a high of $72.51. Yesterday, the shares fell 4.9%, which took the trading range below the 3-day low of...

IONS : 69.24 (+2.64%)
Akcea and Ionis Announce Approval of WAYLIVRA(R) (volanesorsen) in the European Union

Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), announced today that WAYLIVRA has received conditional marketing authorization...

AKCA : 22.17 (+11.30%)
IONS : 69.24 (+2.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade IONS with:

Business Summary

Ionis Pharmaceuticals, Inc. is a RNA-targeted drug discovery and development company which focuses on developing drugs for severe and rare diseases. Ionis Pharmaceuticals, Inc., formerly known as Isis Pharmaceuticals, Inc., is headquartered in Carlsbad, California.

See More

Key Turning Points

2nd Resistance Point 71.07
1st Resistance Point 70.16
Last Price 69.24
1st Support Level 67.95
2nd Support Level 66.65

See More

52-Week High 86.58
Last Price 69.24
Fibonacci 61.8% 69.14
Fibonacci 50% 63.75
Fibonacci 38.2% 58.36
52-Week Low 40.91

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar